IRIS Accounts Production v25.2.0.378 NI038167 Board of Directors Board of Directors 1.1.24 31.12.24 31.12.24 17/9/25 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhNI0381672023-12-31NI0381672024-12-31NI0381672024-01-012024-12-31NI0381672022-12-31NI0381672023-01-012023-12-31NI0381672023-12-31NI038167ns15:NorthernIreland2024-01-012024-12-31NI038167ns14:PoundSterling2024-01-012024-12-31NI038167ns10:Director12024-01-012024-12-31NI038167ns10:Director22024-01-012024-12-31NI038167ns10:PrivateLimitedCompanyLtd2024-01-012024-12-31NI038167ns10:SmallEntities2024-01-012024-12-31NI038167ns10:Audited2024-01-012024-12-31NI038167ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-31NI038167ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-31NI038167ns10:FullAccounts2024-01-012024-12-31NI038167ns10:CompanySecretary12024-01-012024-12-31NI038167ns10:CompanySecretary22024-01-012024-12-31NI038167ns10:RegisteredOffice2024-01-012024-12-31NI038167ns5:CurrentFinancialInstruments2024-12-31NI038167ns5:CurrentFinancialInstruments2023-12-31NI038167ns5:Non-currentFinancialInstruments2024-12-31NI038167ns5:Non-currentFinancialInstruments2023-12-31NI038167ns5:ShareCapital2024-12-31NI038167ns5:ShareCapital2023-12-31NI038167ns5:CapitalRedemptionReserve2024-12-31NI038167ns5:CapitalRedemptionReserve2023-12-31NI038167ns5:RetainedEarningsAccumulatedLosses2024-12-31NI038167ns5:RetainedEarningsAccumulatedLosses2023-12-31NI038167ns5:LandBuildingsns5:ShortLeaseholdAssets2024-01-012024-12-31NI038167ns5:LongLeaseholdAssetsns5:LandBuildings2024-01-012024-12-31NI038167ns5:PlantMachinery2024-01-012024-12-31NI038167ns5:FurnitureFittings2024-01-012024-12-31NI038167ns5:MotorVehicles2024-01-012024-12-31NI038167ns5:LandBuildingsns5:ShortLeaseholdAssets2023-12-31NI038167ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-31NI038167ns5:PlantMachinery2023-12-31NI038167ns5:LandBuildingsns5:ShortLeaseholdAssets2024-12-31NI038167ns5:LongLeaseholdAssetsns5:LandBuildings2024-12-31NI038167ns5:PlantMachinery2024-12-31NI038167ns5:LandBuildingsns5:ShortLeaseholdAssets2023-12-31NI038167ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-31NI038167ns5:PlantMachinery2023-12-31NI038167ns5:FurnitureFittings2023-12-31NI038167ns5:MotorVehicles2023-12-31NI038167ns5:FurnitureFittings2024-12-31NI038167ns5:MotorVehicles2024-12-31NI038167ns5:FurnitureFittings2023-12-31NI038167ns5:MotorVehicles2023-12-31NI038167ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31NI038167ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31NI038167ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-12-31NI038167ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-12-31NI038167ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-12-31NI038167ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-12-31NI038167ns5:Secured2024-12-31NI038167ns5:Secured2023-12-31NI03816712024-01-012024-12-31
REGISTERED NUMBER: NI038167 (Northern Ireland)















Financial Statements for the Year Ended 31 December 2024

for

Fortress Diagnostics Ltd

Fortress Diagnostics Ltd (Registered number: NI038167)






Contents of the Financial Statements
for the year ended 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Fortress Diagnostics Ltd

Company Information
for the year ended 31 December 2024







DIRECTORS: Dr M Afrasiabi
Dr Z Zolnourian



SECRETARIES: Dr Z Zolnourian
F G O'Neill



REGISTERED OFFICE: 9a The Technology Park
Antrim
BT41 1QS



REGISTERED NUMBER: NI038167 (Northern Ireland)



AUDITORS: Cleaver Black
Chartered Accountants
Registered Auditors
Suite 5 Ormeau House
91-97 Ormeau Road
Belfast
Co. Antrim
BT7 1SH



SOLICITORS: Conway Todd & Co
Mirtna Buildings
22 Market Square
Antrim
BT41 4DT

Fortress Diagnostics Ltd (Registered number: NI038167)

Balance Sheet
31 December 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 4 4,787,330 5,142,034

CURRENT ASSETS
Stocks 5 1,935,294 2,391,548
Debtors 6 8,542,598 6,420,134
Cash at bank 598,404 693,885
11,076,296 9,505,567
CREDITORS
Amounts falling due within one year 7 (2,242,455 ) (1,570,193 )
NET CURRENT ASSETS 8,833,841 7,935,374
TOTAL ASSETS LESS CURRENT
LIABILITIES

13,621,171

13,077,408

CREDITORS
Amounts falling due after more than one
year

8

(550,095

)

(898,341

)

PROVISIONS FOR LIABILITIES (1,062,463 ) (1,147,232 )
NET ASSETS 12,008,613 11,031,835

CAPITAL AND RESERVES
Called up share capital 9 9
Capital redemption reserve 81,500 81,500
Retained earnings 11,927,104 10,950,326
12,008,613 11,031,835

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2025 and were signed on its behalf by:




Dr M Afrasiabi - Director



Dr Z Zolnourian - Director


Fortress Diagnostics Ltd (Registered number: NI038167)

Notes to the Financial Statements
for the year ended 31 December 2024

1. STATUTORY INFORMATION

Fortress Diagnostics Ltd is a private company, limited by shares , registered in Northern Ireland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Revenue
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the
Company and the revenue can be reliably measured. Revenue is measured as the fair value of the
consideration received or receivable, excluding discounts, rebates, value added tax and other sales
taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:

1.The Company has transferred the significant risks and rewards of ownership to the buyer;

2.
associated with ownership nor effective control over the goods sold;The Company retains neither
continuing managerial involvement to the degree usually
3.The amount of revenue can be measured reliably;
4.It is probable that the Company will receive the consideration due under the transaction; and
5.The costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Short leasehold - 25% on cost
Long leasehold - 2% on cost
Plant and machinery - 15% on cost
Fixtures and fittings - 15% on cost
Motor vehicles - 25% on cost

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.


Fortress Diagnostics Ltd (Registered number: NI038167)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are
recognised when paid. Final equity dividends are recognised when approved by the shareholders at
an annual general meeting.

Going concern
The directors of Fortress Diagnostics Limited have reviewed the resources available and believe that
the company has adequate resources to continue in operational existence for the foreseeable future.

Accordingly, Fortress Diagnostics Limited continues to adopt the going concern basis in preparing
the financial statements.

Government grants
Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to
expenditure on tangible fixed assets are credited to profit or loss at the same rate as the
depreciation on the assets to which the grant relates. The deferred element of grants is included in
creditors as deferred income.

Grants of a revenue nature are recognised in the Statement of Comprehensive Income in the same
period as the related expenditure.

Fortress Diagnostics Ltd (Registered number: NI038167)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 60 (2023 - 48 ) .

4. TANGIBLE FIXED ASSETS
Short Long Plant and
leasehold leasehold machinery
£    £    £   
COST
At 1 January 2024 58,357 4,395,275 1,829,581
Additions - - 36,333
At 31 December 2024 58,357 4,395,275 1,865,914
DEPRECIATION
At 1 January 2024 51,777 545,060 810,656
Charge for year 581 167,125 169,729
At 31 December 2024 52,358 712,185 980,385
NET BOOK VALUE
At 31 December 2024 5,999 3,683,090 885,529
At 31 December 2023 6,580 3,850,215 1,018,925

Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 January 2024 513,500 69,858 6,866,571
Additions 8,606 - 44,939
At 31 December 2024 522,106 69,858 6,911,510
DEPRECIATION
At 1 January 2024 303,946 13,098 1,724,537
Charge for year 44,743 17,465 399,643
At 31 December 2024 348,689 30,563 2,124,180
NET BOOK VALUE
At 31 December 2024 173,417 39,295 4,787,330
At 31 December 2023 209,554 56,760 5,142,034

5. STOCKS
2024 2023
£    £   
Raw materials 1,351,239 417,104
Work-in-progress 373,277 781,851
Finished goods 210,778 1,192,593
1,935,294 2,391,548

Fortress Diagnostics Ltd (Registered number: NI038167)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 428,110 1,497,383
Amounts owed by group undertakings 4,703,524 2,825,996
Amounts owed by participating interests 2,377,124 1,617,660
VAT - 13,785
Prepayments and accrued income 1,033,840 465,310
8,542,598 6,420,134

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 266,157 236,838
Other loans 33,470 33,470
Hire purchase contracts 7,851 7,851
Trade creditors 1,157,016 1,466,810
Tax (552,264 ) (694,987 )
Social security and other taxes 22,031 26,385
VAT 72,545 -
Other creditors 257,788 357,837
Directors' current accounts 225,237 135,977
Accruals and deferred income 752,624 12
2,242,455 1,570,193

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans - 1-2 years 433,788 739,784
Other loans - 1-2 years 89,253 122,723
Hire purchase contracts 27,054 35,834
550,095 898,341

9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 699,612 -

The bank loans are secured on premises at Antrim Technology Park, Antrim, County Antrim, together
with a fixed and floating charge over the assets of the company and a company guarantee in favour of
Biorex Diagnostics Limited. The directors have also provided a joint and several guarantee in the amount
of £250,000, and the assignment of a life insurance policy.

The other loan is secured on certain assets identified in the loan agreement.

Fortress Diagnostics Ltd (Registered number: NI038167)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

10. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Anthony Bradley FCA (Senior Statutory Auditor)
for and on behalf of Cleaver Black

11. RELATED PARTY DISCLOSURES

The company has taken advantage of the exemption in FRS102 Section 33 "Related party disclosures" from disclosing transactions with related parties that are wholly owned by Fortress Group Holdings Limited.

The Company trades with other related parties as noted below:

20242023
£   £   
Sales to related undertakings1,695,8992,755,067
Purchases from related undertakings951,0001,066,220
Amounts owed by related undertakings2,377,1241,871,660
Amounts owed to related undertakings-156,193

12. POST BALANCE SHEET EVENTS

There were no events since the balance sheet date that would require adjustment or disclosure in the
financial statements.

13. PARENT UNDERTAKING

The ultimate parent undertaking continues to be Fortress Group Holdings Limited, a company incorporated in Northern Ireland.